Cargando…
Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis
INTRODUCTION: Two vaccines against rotavirus gastroenteritis (RVGE) in young children, Rotarix and RotaTeq, have been available in Europe since 2006. Vaccination against rotaviruses significantly reduces the burden of RVGE, but it is also associated with a very small increased risk of intussusceptio...
Autores principales: | Ledent, Edouard, Arlegui, Hugo, Buyse, Hubert, Basile, Peter, Karkada, Naveen, Praet, Nicolas, Nachbaur, Gaëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878204/ https://www.ncbi.nlm.nih.gov/pubmed/29589230 http://dx.doi.org/10.1007/s40259-018-0273-6 |
Ejemplares similares
-
Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review
por: Arlegui, Hugo, et al.
Publicado: (2020) -
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
por: Arlegui, Hugo, et al.
Publicado: (2020) -
Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis
por: Ledent, Edouard, et al.
Publicado: (2016) -
Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines
por: Arlegui, Hugo, et al.
Publicado: (2020) -
The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014)